“…We extracted data from grey literature, empirical literature, and data collected by the Australian Genomic Health Alliance. Nine key informants working in clinical genomics critiqued early drafts of the picture, and validated the final version. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: A descriptive study (N = 1265) was undertaken using self-report data derived from a cross-sectional telephone survey of Australian adults, undertaken in 2017. RESULTS: Fifteen per cent (n = 184) of participants identified as having a mental health condition in the past 12 months. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PURPOSE: This study aimed to compare persistence between patients prescribed intravitreal aflibercept (IVT-AFL) for neovascular age-related macular degeneration (nAMD) in Australia enrolled on a patient support program (PSP) with that of a sample of patients from the Australian Pharmaceutical Benefits Scheme (PBS) dataset (10% PBS sample); explore predictors of persistence; describe changes in patient beliefs over the course of their enrollment in a PSP for patients treated with IVT-AFL for nAMD; and assess patient satisfaction. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION: Australian New Zealand Clinical Trials registry: ACTRN12619000638134. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PARTICIPANTS: 34 574 WA born singletons with a 2009, 2012 or 2015 Australian Early Development Census (AEDC) record. MAIN OUTCOME MEASURE: The AEDC measures child development across five domains; Physical Health and Wellbeing, Social Competence, Emotional Maturity, Language and Cognitive Skills (school-based) and Communication Skills and General Knowledge. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Here we characterize the shared risk factors and outcomes for their comorbidity in the Australian Genetics of Depression cohort study (N = 13,839). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…GL0 =-4.2439 + 0.1927 * GL120 + 15.462 * HbA1c If GL120 is equal to 139 mg/dl (in accordance with all recommendations), and HbA1c is equal to 5.9% (in accordance with the recommendations of NICE, Canadian Diabetes Association, Australian Diabetes Association, et al.), the maximal normal value for FG should be equal to 114 mg/dl. …”
Enlace del recurso
Enlace del recurso

“…MAIN BODY: In 2020, the Australian Health Practitioner Regulation Authority released the National Scheme’s Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy 2020–2025 - empowering all registered health practitioners within Australia to provide health care to Aboriginal and Torres Strait Islander Peoples that is inclusive, respectful and safe, as judged by the recipient of care. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: A chromosome-scale genome assembly of P. nodorum Australian reference isolate Sn15, which combined long read sequencing, optical mapping and manual curation, produced 23 chromosomes with 21 chromosomes possessing both telomeres. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DISCUSSION: The results of this study will provide information on clinical and economic outcomes of a model that integrates on-site pharmacists into Australian residential aged care facilities. The results will provide policymakers with recommendations relevant to further implementation of this model. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The radicular and low back pain (LBP) intensity (Vanguard Australian Shares), blood loss, wound infection, reduction, and quality of life (SF-12 scores) were quantified before the surgery, 1, 3, and 6 months after surgery in two groups. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry (ACTRN12621000023853); Pre-results.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION: This trial was registered with the Australian and New Zealand Clinical Trials Registry on 13 June 2017, www.anzctr.org.au, ACTRN12617000866303. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Methods: We used data from the 1973–78 cohort of the Australian Longitudinal Study on Women’s Health for longitudinal analysis over 19 years (N=14127 at survey 1). …”
Enlace del recurso
Enlace del recurso

“…RESULTS: Focus groups were conducted with 20 participants from five Australian states in June–September 2020. Fourteen adults with a MRCD (three of whom also had a child with a MRCD), and six who cared for a child with a MRCD took part. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION: Australian and New Zealand Clinical Trials Registry ACTRN12615000610538; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHOD: A two-stage adaptive parallel group RCT in which Australian smokers who usually purchase packs containing ≥25 cigarettes were randomised to use only packs containing either 20 (intervention) or their usual packs (control) for four weeks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry: trial IDACTRN12618000866202, retrospectively registered on 22/05/2018, . …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION: The study was retrospectively registered with the Australian New Zealand Clinical Trials Registry (Trial ID: ACTRN12618001627246). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…TRIAL REGISTRATION: Australian New Zealand Clinical Trial Registry ACTRN12619000737134. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso